Univariate and multivariate analysis of risk factors for severe clostridium difficile-associated diarrhoea:: Importance of co-morbidity and serum C-reactive protein

被引:47
作者
Hardt, Christian [1 ]
Berns, Thomas [2 ]
Treder, Wolfgang [3 ]
Dumoulin, Franz Ludwig [1 ]
机构
[1] Gemeinschaftskrankenhaus Bonn, Dept Med, D-53113 Bonn, Germany
[2] St Agnes Hosp Bocholt, Dept Surg, D-46399 Bocholt, Germany
[3] Munster Ctr Lab Diagnost, D-48155 Munster, Germany
关键词
clostridium difficile; nosocomial diarrhoea; co-morbidity; C-reactive protein; 30-day mortality;
D O I
10.3748/wjg.14.4338
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate risk factors for severe clostridium difficile associated diarrhoea (CDAD) in hospitalised patients. METHODS: We analysed risk factors for severe CDAD (associated with systemic signs of hypovolemia) in 124 hospitalised patients by retrospective chart review. RESULTS: Severe CDAD was present in 27 patients (22%). Statistical analysis showed a significant association with a higher 30-d mortality (33% vs 4%, P < 0.001) and a higher proportion of longer hospital stay exceeding 14 d (74% vs 52%, P = 0.048). Charlson co-morbidity score (OR 1.29 for 1 point increment, P < 0.05) and serum C-reactive protein at diagnosis (OR 1.15 for 10 mg/L increment, P < 0.001) were independent predictors of severe CDAD. CONCLUSION: Patients with a severe level of co-morbidity and high serum C-reactive protein levels at the time of diagnosis should receive particular attention. (c) 2008 The WJG Press. All rights reserved.
引用
收藏
页码:4338 / 4341
页数:4
相关论文
共 30 条
[1]   Clostridium difficile-associated diarrhea:: Predictors of severity in patients presenting to the emergency department [J].
Andrews, CN ;
Raboud, J ;
Kassen, BO ;
Enns, R .
CANADIAN JOURNAL OF GASTROENTEROLOGY, 2003, 17 (06) :369-373
[2]   An update on diagnosis, treatment, and prevention of Clostridium difficile -: Associated disease [J].
Aslam, Saima ;
Musher, Daniel M. .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2006, 35 (02) :315-+
[3]   The new Clostridium difficile -: What does it mean? [J].
Bartlett, JG ;
Perl, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2503-2505
[4]   Narrative review: The new epidemic of clostridium difficile-associated enteric disease [J].
Bartlett, John G. .
ANNALS OF INTERNAL MEDICINE, 2006, 145 (10) :758-764
[5]   Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain [J].
Carignan, Alex ;
Allard, Catherine ;
Pepin, Jacques ;
Cossette, Benoit ;
Nault, Vincent ;
Valiquette, Louis .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) :1838-1843
[6]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[7]   Clostridium difficile colitis associated with chronic renal failure [J].
Cunney, RJ ;
Magee, C ;
McNamara, E ;
Smyth, EG ;
Walshe, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (11) :2842-2846
[8]  
Dharmarajan TS, 2000, WORLD J GASTROENTERO, V6, P198
[9]   Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease [J].
Dial, S ;
Delaney, JAC ;
Barkun, AN ;
Suissa, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (23) :2989-2995
[10]   Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy [J].
Dial, Sandra ;
Delaney, J. A. Chris ;
Schneider, Verena ;
Suissa, Samy .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 175 (07) :745-748